About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Progress of Plant-made Vaccines and Therapeutics

by Angela Mohan on August 13, 2021 at 12:16 PM
Font : A-A+

Progress of Plant-made Vaccines and Therapeutics

Advances in technology and manufacturing could boost the uptake of therapeutics derived from plants.

Therapeutic proteins such as antibodies, hormones, cytokines, and proteins in vaccines are generally produced in bacteria or eukaryotic systems, including chicken eggs and mammalian or insect cell cultures.

Advertisement


In 1986, scientists proposed the use of plants for the production of these proteins; called "molecular farming," this process can be less resource-intensive, less costly, and less likely to be a source of contaminants.

So far, one plant-derived therapeutic protein for human use has been approved (in 2012, for Gaucher disease). In 2019, a plant-produced influenza virus vaccine completed phase 3 clinical trials with promising results, and in spring 2021, phase 3 trials for a plant-made vaccine against SARS-CoV-2 began.
Advertisement

Fausther-Bovendo and Kobinger highlight several advantages that plant-produced proteins hold for vaccine development, in particular, citing the strong immune response the plant components of virus-like particles in vaccines can generate, which may reduce the need for adjuvants.

Given orally, plant-made therapeutics are also interesting to consider, say Fausther-Bovendo and Kobinger; they might require minimal processing, thus possibly skipping expensive and time-consuming steps in the manufacturing process.

Edible vaccines - still predominantly in the preclinical stage of development - are also currently under development, the authors note.

Compared to proof-of-concept edible vaccines tested decades ago, which generated weak immune responses, new edible plant-made vaccines could now generate more powerful immune responses, thanks to improved technology.

Because doses for therapeutics are much higher than for vaccines, investment in manufacturing infrastructure must increase to achieve large-scale manufacturing of plant therapeutic products, Fausther-Bovendo and Kobinger say.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Black Pepper as Preventive Measure Against Omicron
FODMAP Diet: A Beginner's Guide
Smallpox
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Vaccination for Children 

Recommended Reading
Plant-derived Compounds Could Help in Cancer Fight
Garlic, broccoli, medicinal-plants derived compounds could offer protection against breast cancer, ....
Vaccination for Children
Vaccines are biological products that impart immunity to the recipient. Vaccines may be live attenua...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use